Richie Soong,
Senior Principle Investigator,
National University of Singapore
Born and bred in Australia, Richie Soong graduated with a PhD from the Department of Surgery at The University of Western Australia with a thesis on the clinical relevance of p53 alterations. He then spent one year at Tan Tock Seng Hospital in Singapore before moving to Roche Diagnostics in Penzberg, Germany. At Roche, he was involved in developing systems and applications for the LightCycler (real-time PCR) instrument, including technology for efficient multiplex PCR and reliable low-level molecule detection. Richie then joined the faculty at the University of Alabama at Birmingham and expanded his research to pharmacogenetics, fluoropyrimidines and DNA methylation under the mentorship of Robert Diasio. Coming to Singapore in 2004, Richie is now a Senior Principal Investigator (Cancer Science Institute of Singapore) and a Research Associate Professor (Department of Pathology) at the National University of Singapore. He is also the Chief of the Centre for Translational Research and Diagnostics (CTRAD), which combines the largest biosample repository in Singapore, a USD$4 million translational research laboratory and two clinical molecular diagnostics centres to provide a unique centre for translating cutting-edge research and delivering diagnostics and therapeutics in the region.
Implementing Next Generation Sequencing Diagnostics in Asia
Tuesday, 12 November 2013 at 17:15
Add to Calendar ▼2013-11-12 17:15:002013-11-12 18:15:00Europe/LondonImplementing Next Generation Sequencing Diagnostics in AsiaGenomics Research Asia in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com
Next generation sequencing (NGS) promises much to clinical diagnostics with its digital output, speed, and depth and breadth of coverage. However, to realize this promise, numerous issues need to be addressed. Technical issues include the selection of targets and assay formats, generation of validation data, handling of low level variants and bioinformatics. Cultural issues include the development of expertise, change management and centralization models. Financial issues include finding the right balance between cost, demand, and throughput. Regulatory issues include quality assurance, legal and ethics concerns. Moreover, the subtleties of Asian healthcare systems mean a significant degree of self-configuration needs to be undertaken. Our efforts to address these issues will be covered in the context of a pilot study on introducing screening for inherited cancer predisposition.
Add to Calendar ▼2013-11-12 00:00:002013-11-13 00:00:00Europe/LondonGenomics Research AsiaGenomics Research Asia in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com